Clinical trial
Efficacy Evaluation of Electronic Psychometric Hepatic Encephalopathy Score (PHES) in Diagnosing Hepatic Encephalopathy Based on a Randomized Crossover Design
NCT07874204 is registered in ClinicalTrials.gov with The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy Evaluation of Electronic Psychometric Hepatic Encephalopathy Score (PHES) in Diagnosing Hepatic Encephalopathy Based on a Randomized Crossover Design
- Lead sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- October 31, 2026
- Completion date
- December 31, 2026
- Enrollment
- 80 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
hepatic encephalopathy (he), liver cirrhosis, minimal hepatic encephalopathy